Structural and Biological Features of FOXP3 Dimerization Relevant to Regulatory T Cell Function

Cell Reports

Volumn 1, Issue 6, 2012, Pages 665-675

  Song, Xiaomin ^a,c   Li, Bin ^b,c   Xiao, Yan ^c   Chen, Chunxia ^c   Wang, Qiang ^c,f   Liu, Yujie ^c   Berezov, Alan ^c,f   Xu, Chen ^d   Gao, Yayi ^b   Li, Zhiyuan ^b   Wu, Shiaw Lin ^e   Cai, Zheng ^c   Zhang, Hongtao ^c   Karger, Barry L ^e   Hancock, Wayne W ^c   Wells, Andrew D ^c   Zhou, Zhaocai ^a   Greene, Mark I ^c  

^a INSTITUTE OF BIOCHEMISTRY AND CELL BIOLOGY   (China)

^b INSTITUTE PASTEUR OF SHANGHAI   (China)

^c UNIVERSITY OF PENNSYLVANIA   (United States)

^d BRANDEIS UNIVERSITY   (United States)

^e NORTHEASTERN UNIVERSITY   (United States)

^f CEDARS SINAI MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DIMER; INTERLEUKIN 2; LYSINE; TRANSCRIPTION FACTOR FOXP3;

ALPHA HELIX; ANIMAL CELL; ARTICLE; BASIC LEUCINE ZIPPER MOTIF; COILED COIL DOMAIN; CONFORMATIONAL TRANSITION; CONTROLLED STUDY; CRYSTAL STRUCTURE; CRYSTALLIZATION; DIMERIZATION; GENE DELETION; GENE EXPRESSION; HISTONE ACETYLATION; HUMAN; HYDROGEN BOND; IN VITRO STUDY; IN VIVO STUDY; IPEX SYNDROME; LYMPHOCYTE FUNCTION; MOUSE; MUTAGENESIS; MUTATIONAL ANALYSIS; NONHUMAN; PROTEIN ANALYSIS; PROTEIN DOMAIN; PROTEIN FUNCTION; PROTEIN INTERACTION; PROTEIN PROCESSING; PROTEIN STABILITY; REGULATORY T LYMPHOCYTE; STRUCTURE GUIDED MUTAGENESIS; ZINC FINGER MOTIF;

ACETYLATION; AMINO ACID SEQUENCE; ANIMALS; DNA MUTATIONAL ANALYSIS; FORKHEAD TRANSCRIPTION FACTORS; HUMANS; JURKAT CELLS; LEUCINE ZIPPERS; LYSINE; MICE; MODELS, MOLECULAR; MOLECULAR SEQUENCE DATA; MUTATION; PROTEIN BINDING; PROTEIN MULTIMERIZATION; PROTEIN STRUCTURE, SECONDARY; REPRESSOR PROTEINS; STRUCTURE-ACTIVITY RELATIONSHIP; T-LYMPHOCYTES, REGULATORY; TRANSFORMING GROWTH FACTOR BETA; ZINC FINGERS;

EID: 84863212714     PISSN: None     EISSN: 22111247     Source Type: Journal    
DOI: 10.1016/j.celrep.2012.04.012     Document Type: Article

References (44)

1. Bandukwala H.S., Wu Y., Feuerer M., Chen Y., Barboza B., Ghosh S., Stroud J.C., Benoist C., Mathis D., Rao A., Chen L. Structure of a domain-swapped FOXP3 dimer on DNA and its function in regulatory T cells. Immunity 2011, 34:479-491.
2. Bennett C.L., Christie J., Ramsdell F., Brunkow M.E., Ferguson P.J., Whitesell L., Kelly T.E., Saulsbury F.T., Chance P.F., Ochs H.D. The immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome (IPEX) is caused by mutations of FOXP3. Nat. Genet. 2001, 27:20-21.
3. Berezov A., Chen J., Liu Q., Zhang H.T., Greene M.I., Murali R. Disabling receptor ensembles with rationally designed interface peptidomimetics. J. Biol. Chem. 2002, 277:28330-28339.
4. Bettelli E., Dastrange M., Oukka M. Foxp3 interacts with nuclear factor of activated T cells and NF-kappa B to repress cytokine gene expression and effector functions of T helper cells. Proc. Natl. Acad. Sci. USA 2005, 102:5138-5143.
5. Brown J.H., Zhou Z., Reshetnikova L., Robinson H., Yammani R.D., Tobacman L.S., Cohen C. Structure of the mid-region of tropomyosin: bending and binding sites for actin. Proc. Natl. Acad. Sci. USA 2005, 102:18878-18883.
6. Brunkow M.E., Jeffery E.W., Hjerrild K.A., Paeper B., Clark L.B., Yasayko S.A., Wilkinson J.E., Galas D., Ziegler S.F., Ramsdell F. Disruption of a new forkhead/winged-helix protein, scurfin, results in the fatal lymphoproliferative disorder of the scurfy mouse. Nat. Genet. 2001, 27:68-73.
7. Chae W.J., Henegariu O., Lee S.K., Bothwell A.L. The mutant leucine-zipper domain impairs both dimerization and suppressive function of Foxp3 in T cells. Proc. Natl. Acad. Sci. USA 2006, 103:9631-9636.
8. Chatila T.A., Blaeser F., Ho N., Lederman H.M., Voulgaropoulos C., Helms C., Bowcock A.M. JM2, encoding a fork head-related protein, is mutated in X-linked autoimmunity-allergic disregulation syndrome. J. Clin. Invest. 2000, 106:R75-R81.
9. Chen C., Rowell E.A., Thomas R.M., Hancock W.W., Wells A.D. Transcriptional regulation by Foxp3 is associated with direct promoter occupancy and modulation of histone acetylation. J. Biol. Chem. 2006, 281:36828-36834.
10. Fontenot J.D., Gavin M.A., Rudensky A.Y. Foxp3 programs the development and function of CD4+CD25+ regulatory T cells. Nat. Immunol. 2003, 4:330-336.
11. Gambineri E., Torgerson T.R., Ochs H.D. Immune dysregulation, polyendocrinopathy, enteropathy, and X-linked inheritance (IPEX), a syndrome of systemic autoimmunity caused by mutations of FOXP3, a critical regulator of T-cell homeostasis. Curr. Opin. Rheumatol. 2003, 15:430-435.
12. Gambineri E., Perroni L., Passerini L., Bianchi L., Doglioni C., Meschi F., Bonfanti R., Sznajer Y., Tommasini A., Lawitschka A., et al. Clinical and molecular profile of a new series of patients with immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome: inconsistent correlation between forkhead box protein 3 expression and disease severity. J. Allergy Clin. Immunol. 2008, 122. 1105-1112, e1.
13. Godfrey V.L., Wilkinson J.E., Russell L.B. X-linked lymphoreticular disease in the scurfy (sf) mutant mouse. Am. J. Pathol. 1991, 138:1379-1387.
14. Hori S., Nomura T., Sakaguchi S. Control of regulatory T cell development by the transcription factor Foxp3. Science 2003, 299:1057-1061.
15. Khattri R., Cox T., Yasayko S.A., Ramsdell F. An essential role for Scurfin in CD4+CD25+ T regulatory cells. Nat. Immunol. 2003, 4:337-342.
16. Koh K.P., Sundrud M.S., Rao A. Domain requirements and sequence specificity of DNA binding for the forkhead transcription factor FOXP3. PLoS ONE 2009, 4:e8109.
17. Kwon H.S., Lim H.W., Wu J., Schnölzer M., Verdin E., Ott M. Three novel acetylation sites in the Foxp3 transcription factor regulate the suppressive activity of regulatory T cells. J. Immunol. 2012, 188:2712-2721.
18. Li B., Samanta A., Song X., Furuuchi K., Iacono K.T., Kennedy S., Katsumata M., Saouaf S.J., Greene M.I. FOXP3 ensembles in T-cell regulation. Immunol. Rev. 2006, 212:99-113.
19. Li B., Samanta A., Song X., Iacono K.T., Bembas K., Tao R., Basu S., Riley J.L., Hancock W.W., Shen Y., et al. FOXP3 interactions with histone acetyltransferase and class II histone deacetylases are required for repression. Proc. Natl. Acad. Sci. USA 2007, 104:4571-4576.
20. Li B., Samanta A., Song X., Iacono K.T., Brennan P., Chatila T.A., Roncador G., Banham A.H., Riley J.L., Wang Q., et al. FOXP3 is a homo-oligomer and a component of a supramolecular regulatory complex disabled in the human XLAAD/IPEX autoimmune disease. Int. Immunol. 2007, 19:825-835.
21. Li B., Saouaf S.J., Samanta A., Shen Y., Hancock W.W., Greene M.I. Biochemistry and therapeutic implications of mechanisms involved in FOXP3 activity in immune suppression. Curr. Opin. Immunol. 2007, 19:583-588.
22. Lin W., Haribhai D., Relland L.M., Truong N., Carlson M.R., Williams C.B., Chatila T.A. Regulatory T cell development in the absence of functional Foxp3. Nat. Immunol. 2007, 8:359-368.
23. Lopes J.E., Torgerson T.R., Schubert L.A., Anover S.D., Ocheltree E.L., Ochs H.D., Ziegler S.F. Analysis of FOXP3 reveals multiple domains required for its function as a transcriptional repressor. J. Immunol. 2006, 177:3133-3142.
24. Mackey-Cushman S.L., Gao J., Holmes D.A., Nunoya J.I., Wang R., Unutmaz D., Su L. FoxP3 interacts with linker histone H1.5 to modulate gene expression and program Treg cell activity. Genes Immun. 2011, 12:559-567.
25. Ono M., Yaguchi H., Ohkura N., Kitabayashi I., Nagamura Y., Nomura T., Miyachi Y., Tsukada T., Sakaguchi S. Foxp3 controls regulatory T-cell function by interacting with AML1/Runx1. Nature 2007, 446:685-689.
26. Pavletich N.P., Pabo C.O. Crystal structure of a five-finger GLI-DNA complex: new perspectives on zinc fingers. Science 1993, 261:1701-1707.
27. Qin S., Cobbold S.P., Pope H., Elliott J., Kioussis D., Davies J., Waldmann H. " Infectious" transplantation tolerance. Science 1993, 259:974-977.
28. Reynolds C., Damerell D., Jones S. ProtorP: a protein-protein interaction analysis server. Bioinformatics 2009, 25:413-414.
29. Rudensky A.Y., Campbell D.J. In vivo sites and cellular mechanisms of T reg cell-mediated suppression. J. Exp. Med. 2006, 203:489-492.
30. Sakaguchi S., Sakaguchi N., Asano M., Itoh M., Toda M. Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor alpha-chains (CD25). Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases. J. Immunol. 1995, 155:1151-1164.
31. Sakaguchi S., Ono M., Setoguchi R., Yagi H., Hori S., Fehervari Z., Shimizu J., Takahashi T., Nomura T. Foxp3+ CD25+ CD4+ natural regulatory T cells in dominant self-tolerance and autoimmune disease. Immunol. Rev. 2006, 212:8-27.
32. Samanta A., Li B., Song X., Bembas K., Zhang G., Katsumata M., Saouaf S.J., Wang Q., Hancock W.W., Shen Y., Greene M.I. TGF-beta and IL-6 signals modulate chromatin binding and promoter occupancy by acetylated FOXP3. Proc. Natl. Acad. Sci. USA 2008, 105:14023-14027.
33. Schwartz R.H. Natural regulatory T cells and self-tolerance. Nat. Immunol. 2005, 6:327-330.
34. Strelkov S.V., Burkhard P. Analysis of α-helical coiled coils with the program TWISTER reveals a structural mechanism for stutter compensation. J. Struct. Biol. 2002, 137:54-64.
35. Stroud J.C., Wu Y., Bates D.L., Han A., Nowick K., Paabo S., Tong H., Chen L. Structure of the forkhead domain of FOXP2 bound to DNA. Structure 2006, 14:159-166.
36. Tao R., de Zoeten E.F., Ozkaynak E., Chen C., Wang L., Porrett P.M., Li B., Turka L.A., Olson E.N., Greene M.I., et al. Deacetylase inhibition promotes the generation and function of regulatory T cells. Nat. Med. 2007, 13:1299-1307.
37. van Loosdregt J., Vercoulen Y., Guichelaar T., Gent Y.Y., Beekman J.M., van Beekum O., Brenkman A.B., Hijnen D.J., Mutis T., Kalkhoven E., et al. Regulation of Treg functionality by acetylation-mediated Foxp3 protein stabilization. Blood 2010, 115:965-974.
38. Wang B., Lin D., Li C., Tucker P. Multiple domains define the expression and regulatory properties of Foxp1 forkhead transcriptional repressors. J. Biol. Chem. 2003, 278:24259-24268.
39. Wildin R.S., Ramsdell F., Peake J., Faravelli F., Casanova J.L., Buist N., Levy-Lahad E., Mazzella M., Goulet O., Perroni L., et al. X-linked neonatal diabetes mellitus, enteropathy and endocrinopathy syndrome is the human equivalent of mouse scurfy. Nat. Genet. 2001, 27:18-20.
40. Wildin R.S., Smyk-Pearson S., Filipovich A.H. Clinical and molecular features of the immunodysregulation, polyendocrinopathy, enteropathy, X linked (IPEX) syndrome. J. Med. Genet. 2002, 39:537-545.
41. Wu Y., Borde M., Heissmeyer V., Feuerer M., Lapan A.D., Stroud J.C., Bates D.L., Guo L., Han A., Ziegler S.F., et al. FOXP3 controls regulatory T cell function through cooperation with NFAT. Cell 2006, 126:375-387.
42. Xiao Y., Li B., Zhou Z., Hancock W.W., Zhang H., Greene M.I. Histone acetyltransferase mediated regulation of FOXP3 acetylation and Treg function. Curr. Opin. Immunol. 2010, 22:583-591.
43. Ziegler S.F. FOXP3: of mice and men. Annu. Rev. Immunol. 2006, 24:209-226.
44. Zuo T., Wang L., Morrison C., Chang X., Zhang H., Li W., Liu Y., Wang Y., Liu X., Chan M.W., et al. FOXP3 is an X-linked breast cancer suppressor gene and an important repressor of the HER-2/ErbB2 oncogene. Cell 2007, 129:1275-1286.